371 related articles for article (PubMed ID: 30741544)
41. Chemotherapy-induced
Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.
Afaq F; Adhami VM; Ahmad N; Mukhtar H
Oncogene; 2003 Feb; 22(7):1035-44. PubMed ID: 12592390
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
Jiang L; Tao C; He A; He X
World J Surg Oncol; 2014 Dec; 12():383. PubMed ID: 25510179
[TBL] [Abstract][Full Text] [Related]
44. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
45. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
[TBL] [Abstract][Full Text] [Related]
46. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines.
Wang W; McLeod HL; Cassidy J
Int J Cancer; 2003 Apr; 104(4):504-11. PubMed ID: 12584750
[TBL] [Abstract][Full Text] [Related]
47. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells.
Kodach LL; Bos CL; Durán N; Peppelenbosch MP; Ferreira CV; Hardwick JC
Carcinogenesis; 2006 Mar; 27(3):508-16. PubMed ID: 16344270
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
49. (-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.
Chen Y; Wang XQ; Zhang Q; Zhu JY; Li Y; Xie CF; Li XT; Wu JS; Geng SS; Zhong CY; Han HY
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587207
[TBL] [Abstract][Full Text] [Related]
50. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
51. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ
Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
[TBL] [Abstract][Full Text] [Related]
52. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
53. EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells.
Zhou DH; Wang X; Feng Q
Nutr Cancer; 2014; 66(4):636-44. PubMed ID: 24712372
[TBL] [Abstract][Full Text] [Related]
54. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
55. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
[TBL] [Abstract][Full Text] [Related]
56. UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro.
Xia J; Song X; Bi Z; Chu W; Wan Y
Int J Mol Med; 2005 Nov; 16(5):943-50. PubMed ID: 16211268
[TBL] [Abstract][Full Text] [Related]
57. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1.
Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C
Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726
[TBL] [Abstract][Full Text] [Related]
58. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
59. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.
Hwang JT; Ha J; Park IJ; Lee SK; Baik HW; Kim YM; Park OJ
Cancer Lett; 2007 Mar; 247(1):115-21. PubMed ID: 16797120
[TBL] [Abstract][Full Text] [Related]
60. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
